Tang-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "KNSA",
  "NUVL",
  "EWTX",
  "CNTA",
  "INSM",
  "RVMD",
  "ENTA",
  "JAZZ",
  "ACAD",
  "ALXO",
  "BABA",
  "TGTX",
  "ALL",
  "PTCT",
  "AXP",
  "ANIP",
  "ABCL",
  "ADMA",
  "AAT",
  "GLPG",
  "GMAB",
  "DVAX",
  "NVAX",
  "MGX",
  "SWTX",
  "TCRX",
  "AVDL",
  "AUPH",
  "RCKT",
  "ARVN",
  "ANAB",
  "ALT",
  "ATXS",
  "SLRN",
  "TBPH",
  "RLAY",
  "MIRM",
  "THRD",
  "NUVB",
  "LENZ",
  "LQDA",
  "ACET",
  "MNMD",
  "STOK",
  "TECX",
  "MLYS",
  "REPL",
  "PHAT",
  "SNDX",
  "NMRA",
  "KROS",
  "LEGN",
  "ALGS",
  "AFMD",
  "ALLK",
  "ATHA",
  "AMLX",
  "JANX",
  "APLT",
  "ATRA",
  "BIOA",
  "BCAB",
  "HD",
  "BLUE",
  "BOLT",
  "AZN",
  "MCD",
  "EPIX",
  "SYRE",
  "APGE",
  "FATE",
  "TARS",
  "IVVD",
  "NBIX",
  "META",
  "KALV",
  "MGNX",
  "NXTC",
  "OABI",
  "NKTX",
  "OTLK",
  "OKUR",
  "QNCX",
  "PYXS",
  "PBYI",
  "SEER",
  "MCRB",
  "LAB",
  "STRO",
  "IONS",
  "IOVA",
  "CYBN",
  "BLCO",
  "ATYR",
  "MSFT",
  "TMUS",
  "GE",
  "HRTX",
  "HRL",
  "IBRX",
  "ZYME",
  "PAYX",
  "PYPL",
  "UNH",
  "NVDA",
  "HPE",
  "INTC",
  "PFE",
  "PG",
  "VZ",
  "REGN",
  "SHW",
  "TXN",
  "UAL",
  "DTIL",
  null,
  "MRNA",
  "LXRX",
  "PLRX",
  "SLNO",
  "PASG",
  "RVPH",
  "ULTA",
  "SNY",
  "GSK",
  "GRAL",
  "ARE",
  "F",
  null,
  "CMPS",
  "ELEV",
  "ERAS",
  "EOLS",
  "FTRE",
  "IMCR",
  "HRMY",
  "DSGN",
  "HLVX",
  "ITOS",
  "KLRS",
  "DERM",
  "KRON",
  "KURA",
  "KOD",
  "IDXX",
  "KZR",
  "AMZN",
  "VNDA",
  "VTYX",
  "VSTM",
  "VTRS",
  "V",
  "VKTX",
  "VIR",
  "VRDN",
  "WMT",
  "WHR",
  "ZNTL",
  "ELAN",
  "OPRX",
  "VERA",
  "BIIB",
  "BHVN",
  null,
  "TDOC",
  "SEE",
  "LNTH",
  "GEV",
  "PCVX",
  "FDX",
  "AVIR",
  "BRK-B",
  "BEAM",
  null,
  "BDTX",
  "BCRX",
  "BNTX",
  "BA",
  "CCCC",
  "CDNA",
  "CAPR",
  "CRGX",
  "SAVA",
  "IPSC",
  "CVX",
  "CLX",
  "KO",
  "CHRS",
  "CMPX",
  "CRBP",
  "CRSP",
  "CGEM",
  "CTMX",
  "CYTK",
  "DNTH",
  "NKE",
  "DIS",
  "XOM",
  "JNJ",
  "NFLX",
  "JPM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 202
Total Value: 1807581363
Accession Number: 0001214659-25-007882
Form Type: 13F-HR
CIK: tang-capital-management
Manager Name: Tang-Capital-Management

Data Enrichment

98% identified

198 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

202 positions • $1.8B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 10 of 11

Sort by:

LEXICON PHARMACEUTICALS, INC.

LXRX|528872302

Shares:1.2M

Value:$530.0K

% of Portfolio:0.0% ($530.0K/$1.8B)

Passage BIO, Inc.

PASG|702712100

Shares:1.5M

Value:$529.6K

% of Portfolio:0.0% ($529.6K/$1.8B)

Outlook Therapeutics, Inc.

OTLK|69012T305

Shares:400.0K

Value:$488.0K

% of Portfolio:0.0% ($488.0K/$1.8B)

REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH|76152G100

Shares:510.3K

Value:$486.8K

% of Portfolio:0.0% ($486.8K/$1.8B)

BioAtla, Inc.

BCAB|09077B104

Shares:1.4M

Value:$476.5K

% of Portfolio:0.0% ($476.5K/$1.8B)

Atara Biotherapeutics, Inc.

ATRA|046513206

Shares:75.2K

Value:$446.7K

% of Portfolio:0.0% ($446.7K/$1.8B)

STANDARD BIOTOOLS INC.

LAB|34385P108

Shares:407.8K

Value:$440.4K

% of Portfolio:0.0% ($440.4K/$1.8B)

Century Therapeutics, Inc.

IPSC|15673T100

Shares:900.0K

Value:$428.4K

% of Portfolio:0.0% ($428.4K/$1.8B)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:100.0K

Value:$354.0K

% of Portfolio:0.0% ($354.0K/$1.8B)

CASSAVA SCIENCES INC

SAVA|14817C107

Shares:200.0K

Value:$300.0K

% of Portfolio:0.0% ($300.0K/$1.8B)

GRAIL, Inc.

GRAL|384747101

Shares:11.3K

Value:$288.6K

% of Portfolio:0.0% ($288.6K/$1.8B)

Kodiak Sciences Inc.

KOD|50015M109

Shares:100.0K

Value:$280.5K

% of Portfolio:0.0% ($280.5K/$1.8B)

MACROGENICS INC

MGNX|556099109

Shares:218.9K

Value:$277.9K

% of Portfolio:0.0% ($277.9K/$1.8B)

Quince Therapeutics, Inc.

QNCX|22053A107

Shares:184.4K

Value:$245.2K

% of Portfolio:0.0% ($245.2K/$1.8B)

Invivyd, Inc.

IVVD|00534A102

Shares:400.0K

Value:$242.1K

% of Portfolio:0.0% ($242.1K/$1.8B)

NextCure, Inc.

NXTC|65343E108

Shares:404.1K

Value:$194.1K

% of Portfolio:0.0% ($194.1K/$1.8B)

Metagenomi, Inc.

MGX|59102M104

Shares:135.0K

Value:$183.6K

% of Portfolio:0.0% ($183.6K/$1.8B)

008064107

Shares:69.8K

Value:$175.1K

% of Portfolio:0.0% ($175.1K/$1.8B)

Athira Pharma, Inc.

ATHA|04746L104

Shares:600.0K

Value:$170.9K

% of Portfolio:0.0% ($170.9K/$1.8B)

Seres Therapeutics, Inc.

MCRB|81750R102

Shares:203.9K

Value:$142.8K

% of Portfolio:0.0% ($142.8K/$1.8B)

Instrument	Shares		Other Manager	Value	% of Portfolio
LEXICON PHARMACEUTICALS, INC.(LXRXcusip528872302)	1.2M	QoQ +35.28% (-300.0K) YoY NEW(+1.2M)	All Managers (Combined)	$530.0K	0.0% ($530.0K/$1.8B)	QoQ -15.58% (-$97.9K) YoY NEW(+$530.0K)
Passage BIO, Inc.(PASGcusip702712100)	1.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$529.6K	0.0% ($529.6K/$1.8B)	QoQ -37.73% (-$321.0K) YoY -73.84% (-$1.5M)
Outlook Therapeutics, Inc.(OTLKcusip69012T305)	400.0K	QoQ +119.17% (+217.5K) YoY -75.29% (-1.2M)	All Managers (Combined)	$488.0K	0.0% ($488.0K/$1.8B)	QoQ +41.47% (+$143.1K) YoY -97.47% (-$18.8M)
REVIVA PHARMACEUTICALS HOLDINGS, INC.(RVPHcusip76152G100)	510.3K	QoQ +200.19% (+340.3K) YoY NEW(+510.3K)	All Managers (Combined)	$486.8K	0.0% ($486.8K/$1.8B)	QoQ +58.19% (+$179.1K) YoY NEW(+$486.8K)
BioAtla, Inc.(BCABcusip09077B104)	1.4M	QoQ 0.00% (-0) YoY -6.78% (-100.0K)	All Managers (Combined)	$476.5K	0.0% ($476.5K/$1.8B)	QoQ -41.33% (-$335.8K) YoY -90.60% (-$4.6M)
Atara Biotherapeutics, Inc.(ATRAcusip046513206)	75.2K	QoQ 0.00% (-0) YoY NEW(+75.2K)	All Managers (Combined)	$446.7K	0.0% ($446.7K/$1.8B)	QoQ -55.37% (-$554.2K) YoY NEW(+$446.7K)
STANDARD BIOTOOLS INC.(LABcusip34385P108)	407.8K	QoQ 0.00% (-0) YoY NEW(+407.8K)	All Managers (Combined)	$440.4K	0.0% ($440.4K/$1.8B)	QoQ -38.28% (-$273.2K) YoY NEW(+$440.4K)
Century Therapeutics, Inc.(IPSCcusip15673T100)	900.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$428.4K	0.0% ($428.4K/$1.8B)	QoQ -52.87% (-$480.6K) YoY -88.61% (-$3.3M)
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	100.0K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$354.0K	0.0% ($354.0K/$1.8B)	QoQ -6.34% (-$24.0K) YoY +24.64% (+$70.0K)
CASSAVA SCIENCES INC(SAVAcusip14817C107)	200.0K	QoQ NEW(+200.0K) YoY NEW(+200.0K)	All Managers (Combined)	$300.0K	0.0% ($300.0K/$1.8B)	QoQ NEW(+$300.0K) YoY NEW(+$300.0K)
GRAIL, Inc.(GRALcusip384747101)	11.3K	QoQ -94.35% (-188.7K) YoY NEW(+11.3K)	All Managers (Combined)	$288.6K	0.0% ($288.6K/$1.8B)	QoQ -91.91% (-$3.3M) YoY NEW(+$288.6K)
Kodiak Sciences Inc.(KODcusip50015M109)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$280.5K	0.0% ($280.5K/$1.8B)	QoQ NEW(+$280.5K) YoY NEW(+$280.5K)
MACROGENICS INC(MGNXcusip556099109)	218.9K	QoQ 0.00% (-0) YoY NEW(+218.9K)	All Managers (Combined)	$277.9K	0.0% ($277.9K/$1.8B)	QoQ -60.92% (-$433.3K) YoY NEW(+$277.9K)
Quince Therapeutics, Inc.(QNCXcusip22053A107)	184.4K	QoQ NEW(+184.4K) YoY -93.74% (-2.8M)	All Managers (Combined)	$245.2K	0.0% ($245.2K/$1.8B)	QoQ NEW(+$245.2K) YoY -92.15% (-$2.9M)
Invivyd, Inc.(IVVDcusip00534A102)	400.0K	QoQ +21.14% (+69.8K) YoY NEW(+400.0K)	All Managers (Combined)	$242.1K	0.0% ($242.1K/$1.8B)	QoQ +65.49% (+$95.8K) YoY NEW(+$242.1K)
NextCure, Inc.(NXTCcusip65343E108)	404.1K	QoQ -42.26% (-295.9K) YoY +179.64% (-259.6K)	All Managers (Combined)	$194.1K	0.0% ($194.1K/$1.8B)	QoQ -64.03% (-$345.6K) YoY -39.76% (-$128.2K)
Metagenomi, Inc.(MGXcusip59102M104)	135.0K	QoQ NEW(+135.0K) YoY NEW(+135.0K)	All Managers (Combined)	$183.6K	0.0% ($183.6K/$1.8B)	QoQ NEW(+$183.6K) YoY NEW(+$183.6K)
(cusip008064107)✕	69.8K	QoQ NEW(+69.8K) YoY NEW(+69.8K)	All Managers (Combined)	$175.1K	0.0% ($175.1K/$1.8B)	QoQ NEW(+$175.1K) YoY NEW(+$175.1K)
Athira Pharma, Inc.(ATHAcusip04746L104)	600.0K	QoQ 0.00% (-0) YoY -29.63% (-252.7K)	All Managers (Combined)	$170.9K	0.0% ($170.9K/$1.8B)	QoQ -51.44% (-$181.1K) YoY -92.68% (-$2.2M)
Seres Therapeutics, Inc.(MCRBcusip81750R102)	203.9K	QoQ NEW(+203.9K) YoY -77.52% (-703.2K)	All Managers (Combined)	$142.8K	0.0% ($142.8K/$1.8B)	QoQ NEW(+$142.8K) YoY -79.67% (-$559.4K)